A safety assessment of topical calcineurin inhibitors in the treatment of atopic dermatitis.

@article{Lebwohl2006ASA,
  title={A safety assessment of topical calcineurin inhibitors in the treatment of atopic dermatitis.},
  author={Mark G. Lebwohl and Tara L. Gower},
  journal={MedGenMed : Medscape general medicine},
  year={2006},
  volume={8 4},
  pages={8}
}
Atopic dermatitis (AD) is a common childhood disease that can disrupt the lives of patients and their families and, in turn, affect their quality of life. The goal of treatment is the long-term control of AD by minimizing the frequency and severity of flares. Topical corticosteroids of various potencies have been the mainstay of pharmacologic treatment of AD flares. In the past few years, the introduction of topical calcineurin inhibitors (TCIs) has provided physicians with an effective, well… CONTINUE READING